Search Results for keywords:"Heraeus Medical"

Found 2 results

Search Results: keywords:"Heraeus Medical"

💰 Only
Oldest Newest
  • 2021-04067 — Certain Bone Cements and Bone Cement Accessories; Notice of Request for Statements on the Public Interest
    Type:Notice
    Citation:86 FR 12029
    Reading Time:about 4 minutes

    The U.S. International Trade Commission is seeking public comments on potential public interest issues related to a possible violation of Section 337 of the Tariff Act of 1930. The investigation involves certain bone cements and bone cement accessories imported by Heraeus Medical GmbH and Heraeus Medical LLC. If a violation is found, the Commission may issue exclusion and cease and desist orders against these imports. The public is invited to submit comments by March 9, 2021, focusing on how such remedial actions might impact public health, the economy, and consumers in the United States.

    Simple Explanation

    The U.S. International Trade Commission is asking people for their thoughts on whether stopping certain bone cement products from other countries might affect things like people's health or the economy in the U.S. They want these ideas by March 9, 2021, so they can decide if keeping these products out is a good idea.

  • 2021-00996 — Certain Bone Cements, Components Thereof and Products Containing the Same; Notice of Commission Determination Finding No Violation of Section 337; Termination of the Investigation
    Type:Notice
    Citation:86 FR 5249
    Reading Time:about 3 minutes

    The U.S. International Trade Commission investigated a complaint from Heraeus Medical LLC and Heraeus Medical GmbH about misappropriation of trade secrets by companies including Zimmer Biomet Holdings, Inc. The investigation looked into whether these actions violated section 337, which concerns trade practices injuring U.S. industries. Ultimately, the Commission concluded that there was no violation as Heraeus failed to prove the existence of a domestic industry impacted by these actions. Thus, the investigation was terminated without penalties against Zimmer Biomet.

    Simple Explanation

    The U.S. International Trade Commission checked if some companies used secret ideas from another company without permission, but in the end, they decided that no rules were broken, so they stopped looking into it.